Ocular Diseases and Behçet’s Syndrome
Ocular Diseases and Behçet’s Syndrome is a research topic within Ophthalmology. Science Explorer counts 30k research works in it since 1950. 15.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the epidemiology, diagnosis, and management of ocular inflammatory diseases, particularly uveitis and Behçet's disease. It covers topics such as the use of immunosuppressive drugs, anti-TNF therapy, and interferon alpha2a therapy in the treatment of these conditions. Additionally, it discusses the epidemiological patterns and prevalence of ocular inflammatory diseases, including their association with juvenile idiopathic arthritis.
- Uveitis
- Behçet's Disease
- Vogt-Koyanagi-Harada Disease
- Inflammatory Eye Diseases
- Immunosuppressive Therapy
- Anti-TNF Therapy
- Juvenile Idiopathic Arthritis
- Epidemiology
- Interferon Alpha2a Therapy
- Choroiditis
- Research works
- 30k fractional, since 1950
- In the world top 10%
- 4.6k per year above
- Top-10% rate
- 15.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +24% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Ocular Diseases and Behçet’s Syndrome research?
By volume, the United States and China publish the most (998 and 795 works in 2022–2025).
By volume, 2022–2025
- 1 United States 998 works
- 2 China 795 works
- 3 India 536 works
- 4 Türkiye 305 works
- 5 Japan 248 works
- 6 United Kingdom 217 works
- 7 Italy 188 works
- 8 South Korea 162 works
- 9 France 162 works
- 10 Spain 157 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Ocular Diseases and Behçet’s Syndrome research?
By volume in 2022–2025, L V Prasad Eye Institute publishes the most Ocular Diseases and Behçet’s Syndrome research, followed by Sankara Nethralaya and Sun Yat-sen University.
By volume, 2022–2025
- 1 L V Prasad Eye InstituteIndia 48 works
- 2 Sankara NethralayaIndia 41 works
- 3 Sun Yat-sen UniversityChina 33 works
- 4 Aravind Eye HospitalIndia 33 works
- 5 Creative CommonsUnited States 29 works
- 6 All India Institute of Medical SciencesIndia 26 works
- 7 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 26 works
- 8 Sağlık Bilimleri ÜniversitesiTürkiye 25 works
- 9 Narayana NethralayaIndia 23 works
- 10 Post Graduate Institute of Medical Education and ResearchIndia 23 works
Who are the leading researchers in Ocular Diseases and Behçet’s Syndrome?
The most-cited researchers publishing on Ocular Diseases and Behçet’s Syndrome include Tianjing Li, Jost B. Jonas and Tien Yin Wong.
- 1 Tianjing Li United States 13k citations
- 2 Jost B. Jonas Germany 7.7k citations
- 3 Tien Yin Wong Singapore 4.3k citations
- 4 João M. Furtado Brazil 3.7k citations
- 5 Sofia Androudi Greece 3.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Ocular Diseases and Behçet’s Syndrome research done?
The largest centres of Ocular Diseases and Behçet’s Syndrome research in 2022–2025 are Beijing (China), Istanbul (Türkiye), Seoul (South Korea) and London (United Kingdom). Among places with at least 20 works in it, it is an unusually large share of all research in Madurai, Mountain View and Tunis.
Largest cities, 2022–2025
Where it is the local speciality
- MaduraiIN · 34.1 works24×
- Mountain ViewUS · 29.0 works9.5×
- TunisTN · 30.7 works8.4×
Location quotient: how much more of its research is in Ocular Diseases and Behçet’s Syndrome than the world average.
Where is the best place to study Ocular Diseases and Behçet’s Syndrome?
Among universities, judged by research, Post Graduate Institute of Medical Education and Research, Istanbul University-Cerrahpaşa and Chongqing Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Post Graduate Institute of Medical Education and ResearchIndia | 64.0 | 13.6% | 13.0× | 23 | +273.1% |
| 2 | Istanbul University-CerrahpaşaTürkiye | 63.0 | 11.9% | 16.8× | 22 | +282.4% |
| 3 | Chongqing Medical UniversityChina | 56.6 | 27.2% | 8.5× | 15 | +32.1% |
| 4 | Vita-Salute San Raffaele UniversityItaly | 54.2 | 19.3% | 15.9× | 11 | +27.9% |
| 5 | All India Institute of Medical SciencesIndia | 54.0 | 5.9% | 8.1× | 26 | +237.8% |
| 6 | Universidad del RosarioColombia | 51.8 | 17.9% | 24.1× | 9 | — |
| 7 | University of MiamiUnited States | 51.3 | 16.7% | 7.8× | 20 | +37.8% |
| 8 | Wenzhou Medical UniversityChina | 49.2 | 27.9% | 6.0× | 11 | +63.2% |
| 9 | Cairo UniversityEgypt | 48.0 | 8.5% | 5.1× | 21 | +204.2% |
| 10 | Sun Yat-sen UniversityChina | 46.3 | 20.9% | 3.9× | 34 | -10.3% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Ocular Diseases and Behçet’s Syndrome research growing?
Output in 2018–2022 was 24% higher than in 2013–2017, peaking in 2022. The fastest-growing topics are Ocular Diseases and Behçet’s Syndrome.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.